A significant discovery in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This vital malignant inhibitor protein is frequently disabled in many types of cancer, leading uncontrolled https://thebookmarkid.com/story22064672/nanobodies-revive-the-p53-protein-a-promising-pathway-for-malignant-therapy